NEW YORK (GenomeWeb News) — Oxford Nanopore Technologies has raised £35 million ($59 million) from existing and new investors, bringing its total funding since its founding in 2005 to £180 million ($302 million).

The new funding, through a private placement of ordinary shares, comes from investors in the UK, the US, and mainland Europe. The CF Woodford Equity Income Fund, which is managed by Woodford Investment Management, is one of the new investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.